VAHATICOR

At VahatiCor, Inc., a member of the T45 Labs portfolio, we strive to advance the medical technology landscape by creating innovative solutions that address unmet clinical needs and elevate the standard of care. Our goal is to transform patients' lives worldwide, one breakthrough at a time... Our approach to frontline interventional treatment for coronary microvascular disease focuses on rapidly providing relief and empowering patients to reclaim their daily lives. We aim to restore vitality and well-being to those affected by this challenging condition by providing an effective and efficient treatment option... VahatiCor's A-Flux Reducer System™ is an investigational medical device that has not yet been approved by the FDA for commercial distribution in the United States. Any descriptions about the device are based solely on investigational studies and clinical trials, and no such descriptions are intended to be statements regarding the safety or efficacy of the device. VahatiCor has..

Also known as: VahatiCor, Inc.

Primary location: Santa Clara United States